CSE: IZO
OTCQB: IZOZF
FSE: 1R3
Home
IzoView
Presentations
Fact Sheets
Media
IzoView Images
Podcast
Videos
News
FAQ
For Investors
For Clinicians
For Breast Cancer Advocates
Team
Management
Advisors
Investors
Why Invest?
Stock Info
Financials
Contact
Menu
Media
Videos
The IzoView Experience
IzoView Images
Podcast
Videos
IzoView
Presentations
Fact Sheets
Media
IzoView Images
Podcast
Videos
News
Izotropic Prepares New Platforms to Educate and Engage
Izotropic Provides Marketing Update
Izotropic Updates License Agreement Terms with University of California
Izotropic’s U.S. FDA Regulatory Pathway Greenlit, Company Provides Corporate Update
Izotropic Engages International Communications Consultant, Grants Incentive Stock Options & RSUs to Key Personnel, Amends Promissory Note with Primary Lender
Izotropic Completes Pre-Submission Meeting with FDA for Breast Cancer Screening Indication
Izotropic to Present at Investor Conference March 13th
FDA Sets Meeting Date with Izotropic
Izotropic Closes Non-Brokered Private Placement
Izotropic Announces Non-Brokered Private Placement- February 2025
Izotropic Announces Timelines and Milestones to IzoView Product Launch
Izotropic Featured in Announcement of Research and Markets’ U.S. Breast Cancer Analysis and Forecast
Izotropic Announces Team Leading Clinical Study Design and FDA Regulatory Submissions
Izotropic Files Pre-Submission with U.S. FDA for Breast Cancer Screening
FAQ
For Investors
For Clinicians
For Breast Cancer Advocates
Team
Management
Advisors
Investors
Why Invest?
Stock Info
Financials
Contact
